Your browser doesn't support javascript.
loading
Overcoming the Challenges of Pyrazinamide Susceptibility Testing in Clinical Mycobacterium tuberculosis Isolates.
Mok, Simone; Roycroft, Emma; Flanagan, Peter R; Montgomery, Lorraine; Borroni, Emanuele; Rogers, Thomas R; Fitzgibbon, Margaret M.
Afiliação
  • Mok S; Irish Mycobacteria Reference Laboratory, St. James's Centre for Laboratory Medicine and Molecular Pathology, St. James's Hospital, Dublin, Ireland.
  • Roycroft E; Department of Clinical Microbiology, Trinity College Dublin, Dublin, Ireland.
  • Flanagan PR; Irish Mycobacteria Reference Laboratory, St. James's Centre for Laboratory Medicine and Molecular Pathology, St. James's Hospital, Dublin, Ireland.
  • Montgomery L; Department of Clinical Microbiology, Trinity College Dublin, Dublin, Ireland.
  • Borroni E; Irish Mycobacteria Reference Laboratory, St. James's Centre for Laboratory Medicine and Molecular Pathology, St. James's Hospital, Dublin, Ireland.
  • Rogers TR; Department of Clinical Microbiology, Trinity College Dublin, Dublin, Ireland.
  • Fitzgibbon MM; Irish Mycobacteria Reference Laboratory, St. James's Centre for Laboratory Medicine and Molecular Pathology, St. James's Hospital, Dublin, Ireland.
Antimicrob Agents Chemother ; 65(8): e0261720, 2021 07 16.
Article em En | MEDLINE | ID: mdl-33972244

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazinamida / Mycobacterium tuberculosis Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazinamida / Mycobacterium tuberculosis Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article